Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Synta Reports Net Loss For Q2
Synta Pharmaceuticals has reported a net loss attributable to common stockholders of $8.5m, or $0.25 per basic and diluted share, for the second quarter in 2009, compared to
Synta Pharmaceuticals has reported a net loss attributable to common stockholders of $8.5m, or $0.25 per basic and diluted share, for the second quarter in 2009, compared to
Covidien and Nuvo have reported that FDA has extended the review of Pennsaid diclofenac sodium topical solution under the Prescription Drug User Fee Act (PDUFA). During the review
Sagent Pharmaceuticals has launched ondansetron in 5% dextrose injection in premix bags. Its an antiemetic and selective 5-HT3 receptor antagonist used to prevent nausea and vomiting caused by
Repros Therapeutics, in the interest of patient safety, has voluntarily suspended dosing of all patients in its clinical trials of Proellex. The decision is based on available information
Elan Drug Technologies, a business unit of Elan Corporation, has announced the first approval of an injectable formulation using its proprietary NanoCrystal technology. The company said that earlier
Boehringer Ingelheim is going to initiate phase III clinical study of BIBW 2992 (Tovok), as first-line treatment in non-small cell lung cancer (NSCLC) patients with epidermal growth factor
MannKind reported a net loss for the second quarter of 2009 of $55.6 million, or $0.54 per share, compared to a net loss of $79.8 million, or $0.79
Cardinal Health has completed the aquisition of the assets of Biotech, an operator of Positron Emission Tomography (PET) cyclotrons and nuclear pharmacies in the Southwestern US. With the
Watson has received approval from FDA on its Abbreviated New Drug Applications (ANDAs) for metoprolol succinate extended-release Toprol tablets USP, in the 25mg and 50mg strengths. Metoprolol succinate
Micronics has been awarded a Small Business Technology Transfer grant totaling approximately $440,000, to develop a rapid method for nucleic acid detection of known and emerging respiratory infections.